# Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination.

> **NCT00516022** · PHASE2 · COMPLETED · sponsor: **Rambam Health Care Campus** · enrollment: 79 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** Mistletoe extract

## Key facts

- **NCT ID:** NCT00516022
- **Lead sponsor:** Rambam Health Care Campus
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2011-03
- **Final completion:** 2011-05
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2011-09-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00516022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00516022, "Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00516022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*